Patients with a clinically severe bone dysplasia, who lack a specific diagnosis because a collagen mutation was undetectable through standard collagen testing, or families that have experienced unexplained fetal or infantile deaths attributed to type II OI, and/or consanguinity, will be admitted under this protocol for further clinical evaluation and genetic analysis.